Profil
Cynthia Pussinen worked at Actinium Pharmaceuticals, Inc. as Executive Vice President-Technical Development.
Ms. Pussinen worked at Spark Therapeutics, Inc. as Chief Technical Officer from 2021 to 2022.
Ms. Pussinen worked at Sernova Biotherapeutics, Inc. as Chief Executive Officer & Director from 2023 to 2024.
Ms. Pussinen completed undergraduate education at the University of Connecticut and graduate education at Rensselaer Polytechnic Institute.
Ehemalige bekannte Positionen von Cynthia Pussinen
| Unternehmen | Position | Ende |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Vorstandsvorsitzender | 12.08.2024 |
| SPARK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Cynthia Pussinen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
















